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Objective: Intracardiac malformations associated with coarctation and
aortic arch hypoplasia have traditionally been repaired in 2 stages, with
a high mortality rate. We review our experience with single-stage biven-
tricular repair of intracardiac defects associated with aortic arch
hypoplasia by means of pulmonary homograft patch aortoplasty.
Methods: Between October 1988 and October 1997, 39 of 40 consecutive
patients underwent single-stage biventricular repair for aortic arch
obstruction and associated intracardiac defects. The median age at
operation was 17 days and the mean weight was 3.71 ± 1.09 kg. Nineteen
patients had either dextrotransposition of the great arteries or the
Taussig-Bing anomaly. Sixteen patients had multiple left-sided obstruc-
tive lesions (2 cases of critical aortic stenosis, 3 of subaortic stenosis and
ventricular septal defect, and 11 of hypoplastic left heart complex). One
patient had an associated complete atrioventricular septal defect. Four
patients had only an associated ventricular septal defect. Through a
median sternotomy, the hypoplastic aortic arch was enlarged with a pul-
monary homograft patch in 36 patients. In 4 patients an extended end-
to-end anastomosis was performed. Results: There were 2 early deaths
(5%) and 2 late deaths (5%). One late death was not cardiac related.
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A ortic arch obstruction with associated intracardiacdefects has always presented a formidable surgical
challenge. The traditional 2-stage approach of initial
coarctation repair and palliation followed by subse-
quent intracardiac repair has been associated with a
high mortality rate.1-4 A few centers report improved
survival with a single-stage repair of the intracardiac
defect and reconstruction of the hypoplastic aortic arch
almost exclusively through the extended end-to-end
anastomosis technique.1,5-7 In this report we review our
results during a 9-year period with a single-stage repair
of aortic arch hypoplasia and associated intracardiac
defects with pulmonary homograft aortoplasty.
Patients and methods
Between October 1988 and October 1997, 39 of 40 con-
secutive patients with aortic arch hypoplasia and associated
intracardiac defects underwent a single-stage biventricular
repair at the Montreal Children’s Hospital. There were 21
boys and 19 girls. The median age at operation was 17 days
(range 4 days–2 years), with 27 neonates and all except 2
younger than 3 months. The mean weight was 3.70 ± 1.08 kg.
A 10-day-old neonate underwent a 2-stage repair for a
Taussig-Bing anomaly with aortic arch obstruction because
of hemodynamic instability after induction of anesthesia.
This patient initially underwent resection and extended end-
to-end anastomosis and pulmonary artery banding through a
left thoracotomy. He successfully underwent the arterial
switch operation, ventricular septal defect (VSD) closure, and
pulmonary artery debanding at 22 days old.
All patients were evaluated before the operation by 2-
dimensional and Doppler echocardiography. Cardiac cathe-
terization was performed in only a few cases.
All patients had aortic arch obstruction by virtue of
hypoplasia with or without aortic coarctation. Patients with
interrupted aortic arch were excluded from this study, as were
those with a single-ventricle physiology who could not be
considered for a biventricular repair. Aortic arch hypoplasia
was defined as the transverse aortic arch diameter less than
the weight of the baby in kilograms + 1 mm.5 Only 5 patients
did not have a discrete coarctation. The mean diameter of the
ascending aorta for this series was 6.6 ± 1.5 mm. The proxi-
mal aortic arch (between the innominate and left carotid
arteries) and the distal arch (between the left carotid and the
left subclavian arteries) had mean diameters of 4.0 ± 0.8 mm
and 3.1 ± 0.7 mm, respectively. The aortic isthmus (between
the left subclavian artery and the ductus arteriosus) had a
mean diameter of 2.2 ± 0.7 mm.
The heterogeneous set of associated intracardiac defects is
presented in Table I. The patients were divided into 2 groups
according to the presence or absence of additional left-sided
obstructive lesions. Group I consisted of 24 patients without
left-sided obstructive lesions, including 8 patients with
subaortic stenosis and transposition of the great arteries
(TGA) and VSD or the Taussig-Bing anomaly, because that
region is excluded from the systemic circulation after the
repair. Group II consisted of 16 patients with associated left-
sided obstructive lesions, all class II or III according to
Kirklin’s classification.8 Eleven of those patients had the
diagnosis of hypoplastic left heart complex, consisting of
multiple hypoplastic structures in the left heart–aorta com-
plex, including the mitral valve anulus, left ventricular cavi-
ty, left ventricular outflow tract (LVOT), aortic valve anulus,
ascending aorta, and aortic arch. Inclusion criteria included
presence of antegrade aortic flow and absence of intrinsic
aortic valve or mitral valve stenosis, with the obstruction
caused by hypoplasia only. All patients with hypoplastic left
heart complex had LVOT and aortic valve diameters at least
4 SD below the normal mean. They also had a mitral valve
diameter and left ventricular dimensions at least 2 SD below
the normal mean.
Preoperative status. Ductal dependency and administra-
tion of prostaglandin E1 treatment were necessary in 25
patients (63%). Thirty-three patients (83%) were treated for
congestive heart failure. Seventeen patients (43%) were criti-
cally ill, requiring ventilatory support and in some cases ino-
tropic support.
Surgical technique. All patients except 1 (previously
described) underwent single-stage repair through a median
sternotomy with the use of deep hypothermic circulatory
arrest. The often diminutive ascending aorta was carefully
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The mean follow-up time was 36 months (range 1 month-9 years). The
recoarctation rate after pulmonary homograft patch aortoplasty was
8.3%, but after exclusion of those patients with associated left-sided
obstructive lesions this decreased to 0%. No aneurysm formation in the
aorta has occurred. The actuarial survival at 8 years is 89% ± 10%.
Conclusions: Single-stage biventricular repair of aortic arch obstruction
and associated intracardiac defects can achieve excellent survival. We
recommend pulmonary homograft patch aortoplasty because it
achieves complete relief of anatomic afterload with a tension-free anas-
tomosis and low incidence of recoarctation. (J Thorac Cardiovasc Surg
1998;116:897-904)
cannulated on the rightward side near the base of the innom-
inate artery. Single venous cannulation of the right atrium
was used for patients in group II and before 1994 in the
patients in group I. Since 1994, double venous cannulation
was used in these latter patients to perform the intracardiac
repair with cardiopulmonary bypass, reserving circulatory
arrest only for the aortic arch repair. Myocardial protection
was accomplished in all patients with single-dose crystalloid
cardioplegic solution and ice-cold slush solution in the peri-
cardial cavity.
The hypoplastic aortic arch repair was carried out with a
pulmonary homograft patch in 36 patients, according to our
previously published technique.9 This consisted of opening
its undersurface from approximately 1.5 cm distal to the
insertion of the ductus in the upper descending aorta, across
the entire aortic arch and into the ascending aorta. The entire
opened aorta was then enlarged with an appropriately fash-
ioned pulmonary homograft patch. In the transposition com-
plexes the enlargement was carried down to the transected
aorta, thus correcting any size discrepancy present. In the
patients with hypoplastic left heart complex, the entire
ascending aorta was enlarged down to just distal to the aortic
valve commissural posts. In the other patients varying lengths
of the ascending aorta were enlarged according to the length
and degree of hypoplasia. The resection and extended end-to-
end anastomosis was used in only 4 patients, according to the
technique described by the Marie-Lannelongue group.6
The intracardiac repairs were performed by previously
described techniques for each specific malformation. Sub-
aortic stenosis was present in 8 group I patients. In 7 patients
it was resected through the ventriculotomy incision, which
was then enlarged with an outflow pericardial patch. In 1
patient the severely stenotic area could not be enlarged with a
transannular patch because of an abnormal coronary artery.
The patient underwent a modified Damus-Kaye-Stansel/
Rastelli operation. The VSD was closed into the main pul-
monary artery and the systemic circulation was brought over
the transected proximal main pulmonary artery after enlarge-
ment of the aortic arch with a pulmonary homograft patch.
Right ventricle to distal pulmonary artery continuity was
established with a valved pulmonary homograft. In group II, 3
patients with VSD also had subaortic stenosis. One patient
underwent resection with VSD closure. In the second patient
the posterior malalignment VSD was closed through the pul-
monary valve with an undersized patch anchored distally on
the left ventricular aspect of the conal septum, as described by
Luciani and associates.10 The third patient had severe unre-
sectable stenosis and underwent the previously described
modified Damus-Kaye-Stansel/Rastelli operation. All patients
with hypoplastic left heart complex had tunnel subaortic
stenosis, which was treated conservatively.
The mean cardiopulmonary bypass time was 202 ± 70 min-
utes and the mean circulatory arrest time was 52 ± 22 min-
utes. Delayed sternal closure was necessary in 16 cases.
Follow-up. All follow-up data were collected from the
clinic visits to the divisions of cardiovascular surgery and car-
diology. The patients have been followed up annually with
physical examination, chest radiography, and echocardiogra-
phy. The patients with suspected abnormalities were further
assessed with cardiac catheterization or magnetic resonance
imaging. Patients followed up elsewhere had data collected
from parents and referring cardiologists. Mean follow-up
time for all hospital survivors was 36 ± 32 months (range 1
month–9 years).
Results
There were 2 in-hospital deaths among the 40
patients (5%), both in group II. Both early deaths were
in patients with hypoplastic left heart complex. One
patient was unable to come off cardiopulmonary by-
pass because the hypoplastic left side of the heart was
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Table I. Associated intracardiac defects in 40 patients
with aortic arch hypoplasia (with or without coarctation)
Additional anatomic diagnosis No.
Group I
TGA + intact ventricular septum 3
TGA + VSD 4
TGA + VSD + SAS 4
Taussig-Bing anomaly 4
Taussig-Bing anomaly + SAS 4
VSD 4
Complete atrioventricular canal 1
Group II
VSD + SAS 3
Critical aortic stenosis 2
Hypoplastic left heart complex* 11
+ Parachute mitral valve 4
+ VSD 4
+ Partial atrioventricular canal 1
VSD, Ventricular septal defect; SAS, subaortic stenosis.
*See text for definition.
Table II. Summary of results by group
Group I Group II 
(n = 24) (n = 16)
Median age (d) 29 9
Early deaths* 0 2 (13%)
Late deaths* 1 (4%) 1 (6%)
Recurrent aortic arch obstruction* 0 4 (25%)
Patients undergoing reoperation (no.) 2 7
Reoperations (no.) 2 10
For aortic arch obstruction 0 5
For LVOT obstruction 0 5
For other 2 2
Actuarial survival (%) 91% ± 8% 73% ± 16%
Freedom from reoperation 89% ± 8%† 27% ± 8%‡
*Number of patients with percentage in parentheses.
†At 8 years.
‡At 3 years.
unable to support the systemic circulation. Despite
revision to a Norwood operation, the patient died dur-
ing the operation. The other patient acquired persistent
junctional ectopic tachycardia during the postoperative
period, which necessitated systemic cooling. This
patient died during a cardiac catheterization 14 days
after operation that was performed to assess an ex-
tremely small LVOT.
Among the 38 early survivors, the median ventilato-
ry support time was 8 days (range 8 hours–5 months).
The median hospital stay was 24 days (range 6 days–8
months).
There were 2 late deaths, 1 in each group, for an over-
all total mortality rate of 10%. The total mortality rate
in group I was 4.2%; it was 18.8% in group II. In group
I the only death occurred from a hepatoblastoma at 39
months after cardiac repair (parents refused liver trans-
plantation). In group II a late death occurred at 39
months after the original repair, after reoperation for
severe tunnel subaortic stenosis. Severe pulmonary
hypertension and a single right coronary artery were
likely causes of the poor outcome. The actuarial sur-
vival for all patients in this series at 8 years is 89% ±
10%.
There have been 4 known cases of recurrent aortic
arch obstruction; all were managed surgically. All 4
cases occurred in group II. One patient had undergone
initial repair by resection and extended end-to-end
anastomosis. The other 3 recurrences were after pul-
monary homograft patch aortoplasty (3/36 patients,
8.3%). The overall rate of recurrent aortic arch obstruc-
tion was 10% (0% in group I and 25% in group II).
A total of 12 reoperations have been performed in 9
of the 38 early survivors. There were 2 reoperations in
2 patients in group I. One patient underwent reopera-
tion for recurrent pulmonary stenosis and right pul-
monary artery stenosis 21 months after repair of TGA,
VSD, and aortic arch obstruction. The second patient
was reoperated on for severe mitral regurgitation 2
months after repair of complete atrioventricular canal
and aortic arch obstruction. Because of a single papil-
lary muscle, the mitral valve cleft was not closed at the
initial operation. The mitral valve was repaired by pap-
illary muscle splitting and closure of the mitral valve
cleft. Seven patients in group II required 10 reopera-
tions. There were 5 reoperations in 4 patients for recur-
rent aortic arch obstruction, with no deaths. These 4
patients underwent resection and end-to-end anastomo-
sis. One patient with a second recurrence also under-
went another resection and patch aortoplasty. Four
patients underwent 5 reoperations for LVOT obstruc-
tion from 12 to 39 months after the first operation. One
other patient was reoperated on at 14 months for recur-
rent aortic stenosis, both valvular and supravalvular,
and aortic arch obstruction. She underwent a revision
of aortic valvotomy, ascending aortoplasty with a poly-
tetrafluoroethylene patch, and resection of recurrent
aortic arch obstruction with end-to-end anastomosis.
The results are summarized in Table II.
Discussion
The surgical treatment of intracardiac defects with
associated aortic arch obstruction is a challenging
undertaking. Until recently these patients were ap-
proached in 2 stages, with the coarctation repaired first
through a left thoracotomy, often with concomitant pul-
monary artery banding. The intracardiac repair was
deferred to a second procedure. In the last decade a few
centers have been repairing these defects in a single
operation, with improved survival rates.1,5-7,9 In this
report we present our results since 1988 with a consis-
tent single-stage repair of intracardiac defects and aor-
tic arch obstruction with pulmonary homograft patch
aortoplasty.
Traditionally patients with coarctation of the aorta
have been divided into 3 groups: isolated coarctation,
coarctation with VSD, and coarctation with complex
intracardiac defects. The largest multiinstitutional
study, involving 27 institutions, was performed by the
Congenital Heart Surgeons Society.2 Among the 171
patients with isolated coarctation the total mortality
rate was 13%; it was 17% for the 155 patients with
coarctation and VSD. The mortality rate increased to
45%, however, for the 106 patients with coarctation
and complex intracardiac defects. Of particular interest
is the stratification of the coarctation with or without
VSD groups with respect to the presence and number
of associated additional left-sided obstructive lesions.
In the absence of additional left-sided obstructive
lesions, the total mortality was only 8% among 280
patients. One additional left-sided obstructive lesion
(Kirklin class II) was associated with a mortality rate of
40% and the presence of 2 or more additional left-sided
obstructive lesions (Kirklin class III) further increased
the mortality rate to a prohibitive 88%. These dismal
results are probably the reason for the recommendation
that patients with class III hypoplastic left heart syn-
drome be subjected to a univentricular approach.8 It is
also clear that patients with additional left-sided
obstructions should be considered in the complex
coarctation group and that the traditional approach of
coarctation repair through left thoracotomy in these
patients leads to poor results.
The single-stage repair was first reported by Pigott
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and associates11 for 5 patients with TGA and aortic
arch obstruction. There were 4 survivors. The superior-
ity of the single-stage approach was first demonstrated
by Planché and colleagues1 in 1993, also for patients
with TGA, VSD, and aortic arch obstruction. This
experience was further updated by Conte and associ-
ates6 for a total of 71 patients. The total mortality rate
for the single-stage approach in 27 patients was only
19%, as opposed to 45% for the 2-stage approach used
in the other 44 patients. Other authors have also report-
ed improved results with the single-stage approach,
with total mortality rates of around 20%.5,7 In 1997 we
reported no early deaths and only 1 late noncardiac
death among 12 patients with transposition complexes
with aortic arch obstruction treated by the single-stage
approach.9
In the largest series from a single institution on the
surgical management of neonatal coarctation, consist-
ing of 307 patients from Marie-Lannelongue in Paris,
the total mortality rate for isolated coarctation was an
outstanding 2%, and for coarctation with VSD it was
only 6%.6 On the other hand, the mortality rate for the
complex coarctation group (110 patients) was much
higher at 40%. However, the 31 patients treated by a
single-stage operation had a significantly lower mortal-
ity rate (23%) than did the 79 patients subjected to a 2-
stage approach (47%).
The reason for the high mortality rate associated with
the 2-stage approach may be multifactorial. The over-
whelming association of neonatal coarctation with tubu-
lar hypoplasia of the aortic arch has been unrecognized
until recently. Aortic arch hypoplasia was present in
81% of the patients in Conte and associate’s series,6
with the association being highest in the group with
complex intracardiac lesions (93%). Conservative re-
pair of the coarctation in these patients would not ad-
dress the aortic arch hypoplasia, leaving anatomic
obstruction to be faced by the unrepaired heart. For
this reason several groups, including the Marie-
Lannelongue group, advocate an extended end-to-end
technique of repair to a point proximal to the left com-
mon carotid artery.6 Although there is evidence that the
tubular hypoplasia of the aorta grows after simple
coarctation repair,12,13 growth probably does not occur
fast enough to allow consistent survival of the unre-
paired heart. After subsequent repair, the heart freshly
operated on still has to face the residual anatomic after-
load of the hypoplastic arch, decreasing survival.
Furthermore, the placement of a pulmonary artery band
in these patients may lead to a doubly obstructed heart.
Finally, in some patients the complexity of the intracar-
diac malformation may be overwhelming, itself pre-
cluding survival unless repaired, despite an adequate
coarctation repair. The 2-stage approach psychological-
ly elevates the coarctation to the status of primary mal-
formation, relegating the heart defect to a secondary sta-
tus. We believe that it should be the other way around
for most patients with associated intracardiac defects.
The cardiac malformation should take precedence, with
the coarctation being repaired simultaneously.
The controversy also extends to patients with coarc-
tation and VSD, where the difference between the sin-
gle-stage and the 2-stage approach is not as obvious. In
the Congenital Heart Surgeons Society multi-institu-
tional study,2 initial repair of coarctation with con-
comitant pulmonary artery banding carried a mortality
rate of 9%, compared with mortality rates of 21% for
coarctation repair alone and 22% for single-stage repair
of the coarctation and VSD. The difference in mortali-
ty rate, however did not reach statistical significance.
Furthermore, although the lowest mortality rate was
seen among the 34 patients who underwent coarctation
repair and pulmonary artery banding, 18 of those
patients had not yet undergone VSD closure by the
time results were analyzed for the study.
Since 1988, we at the Montreal Children’s hospital
have consistently repaired cardiac defects and associat-
ed aortic arch obstruction with a single operation
through a sternotomy approach. This was possible in
39 of 40 consecutive patients. The early mortality rate
was 5% (2 deaths), with no deaths in group I and a
12.5% mortality rate in group II. The total mortality
rate was 10% (2 late deaths, 1 in each group), with
mortality rates of 4.2% in group I and 18.8% in group
II. These mortality rates are much lower than those
reported in the literature with a 2-stage approach for
similar patients.1,2,4,8,13-15
Only 4 patients in our series (10%) had a VSD and
aortic arch obstruction without additional left-sided
obstructive lesions. These defects were repaired simul-
taneously without any deaths. The single-stage ap-
proach for these patients merits further assessment,
perhaps in a prospective randomized study.
Hypoplastic left heart complex is a term that we
introduced at the Thirty-fourth Annual Meeting of The
Society of Thoracic Surgeons in New Orleans in 1998
to denote a subset of patients with class III hypoplastic
left heart syndrome who should be considered for
biventricular repair.16 We believe that the biventricular
approach will probably result in a better long-term
prognosis than will a univentricular approach, which is
based on the morphologically right ventricle as a sys-
temic pump. Our criteria for biventricular repair are as
follows: (1) antegrade flow in the ascending aorta, (2)
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no intrinsic aortic or mitral valve stenosis (obstruction
by hypoplasia only), and (3) adequate left ventricular
function. The surgical objectives were complete relief
of the extracardiac anatomical afterload, elimination of
all intracardiac shunts to fully preload the left side of
the heart, and a conservative approach to the hypoplas-
tic inflow and outflow tracts of the left ventricle. This
was accomplished with pulmonary homograft patch
aortoplasty of the aortic arch and ascending aorta and
closure of any interventricular and interatrial commu-
nications. We have observed rapid growth of the
hypoplastic left heart structures, with the exception of
the subaortic region.
Several techniques have been proposed through the
years for repair of coarctation and aortic arch hypopla-
sia. Synthetic patch aortoplasty has fallen out of favor
because of the risk of aneurysmal growth and sudden
rupture.17,18 It was first proposed in 1957 to replace the
circumferential suture line in the resection with end-to-
end anastomosis technique for coarctation repair.19 The
incidence of aneurysm formation with the synthetic
patch aortoplasty, now well studied, has ranged from
1.3% to 26%.17,20-22
Complete conduit reconstruction of the aorta in early
life has been avoided as a result of the lack of growth
potential. The subclavian flap angioplasty technique
gained in popularity because of its ease of use and
because it does not require extensive dissection.
However, it does not address the aortic arch hypoplasia
proximal to the left subclavian artery and is not a tech-
nique that can be used with the single-stage approach.
Currently the most widely used technique for repair of
coarctation with aortic arch hypoplasia is resection
with extended end-to-end anastomosis.4-7 The main
advantages of this technique are the resection of the
coarctation shelf and abnormal periductal tissue and the
augmentation of the tubular hypoplasia of the aortic
arch with no foreign material. Disadvantages are the
greater tension at the anastomosis and the potential for
leaving relative obstruction at the proximal end. The
incidence of recoarctation has varied between 4% and
20%, depending on the series and the classification of
the defects.2,4-7
Although a pulmonary homograft patch has been
used widely in the Norwood procedure for hypoplastic
left heart syndrome, its use for repair of coarctation and
aortic arch hypoplasia has remained largely unreported.
The only report of the use of homograft aortoplasty was
by Pigott and associates.11 Our almost exclusive use of
pulmonary homograft patch aortoplasty in the single-
stage repair was based on the following principles: (1)
the aortic arch must be of adequate size after the repair,
regardless of the original diameter, (2) we must have
the ability to enlarge the ascending aorta, particularly
important in the group II patients with multiple left-
sided obstructions, (3) there must be no tension at the
anastomosis, particularly in patients undergoing the
arterial switch operation with circumferential neoaortic
anastomosis, and (4) it is important to correct the
marked discrepancy between the proximal neoaorta
and the distal aorta commonly present in patients
with transposition complexes. We have used this tech-
nique in 90% of our patients since 1988. Our overall
reintervention rate for recoarctation after pulmonary
homograft patch aortoplasty is 8.3%, comparable to the
incidence observed for the extended end-to-end tech-
nique2,4-7 as well as incidences of recoarctation after
the Norwood procedure.23-25 There were no recoarcta-
tions in group I; all reinterventions occurred in the
group II patients with additional left-sided obstruc-
tions. We can only speculate that the residual intracar-
diac obstructions may have led to a borderline cardiac
output with inadequate volume and pressure loading of
the aortic arch. Aneurysm formation has not been
observed in our patients; however, it is too early to
make definitive statements regarding this problem.
Single-stage repair of aortic arch obstruction and
associated intracardiac defects has achieved excellent
survival rates. Results are superior to those published
for the 2-stage approach, and single-stage repair should
therefore be considered the surgical approach of
choice. Furthermore, the extensive enlargement of the
aortic arch and ascending aorta has achieved much
improved survival for the patients with additional left-
sided obstructions. We recommend pulmonary homo-
graft patch aortoplasty because it achieves complete
relief of the anatomic afterload with a tension-free
anastomosis and a low incidence of recoarctation.
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Discussion
Dr Claude Planché (Paris, France). I first congratulate you
on an excellent series with remarkable results in surgical man-
agement of complex cardiac anomalies associated with aor-
tic arch obstruction. Aortic arch obstruction includes a wide
range of anatomic anomalies of various degrees of severity that
should dictate the method of repair. Extended resection and
end-to-end repair require extensive mobilization of the descend-
ing aorta and can be challenging, as you pointed out, when
the proximal aortic arch is involved. Aortic arch reconstruction
with pulmonary homograft patch is a relatively simple stan-
dardized and reproducible technique that is applicable in all
forms, even those involving the ascending aorta. In some
cases, however, a new aorta will consist almost entirely of pros-
thetic material, particularly at the level of the aortic isthmus.
It has been our experience that even pulmonary homograft
can calcify. Can you comment on the technical aspect of sur-
gical management of recoarctation in such a case? Is it possi-
ble to use balloon dilatation? In your series 5 patients did not
have a discrete coarctation but underwent an aortic arch
repair. Can you comment on this particular aspect?
The study confirms our experience that excellent survival
can be achieved with single-stage biventricular repair of com-
plete cardiac anomaly. However, we consider that the 2-stage
management of this anomaly may be preferable in some situ-
ations, such as multiple VSD, straddling atrioventricular
valves, or preoperative brain damage. Can you give your pre-
cise selection criteria for 1- versus 2-stage repair?
With respect to the group of patients with hypoplastic left
ventricle, in our experience with patients with intact ventric-
ular septum and only 1 atrial septal defect, reported on last
year at the American Association for Thoracic Surgery meet-
ing, we observed that isolated coarctation repair was generally
enough to initiate the left ventricular growth; concomitant
closure of the atrial septal defect led to severe left ventricular
diastolic failure. In addition, when analyzing your results, we
observed that the recoarctation rate was nearly 30% among
the survivors of this particular group, despite an adequate
repair and the growth of the left ventricle. Could you com-
ment on these particular points?
I totally agree that use of pulmonary homograft patch is
helpful in repair of the aortic arch obstruction, particularly in
forms involving the ascending aorta and the proximal part of
the aortic arch.
Dr Tchervenkov. We have been inspired by you in many
cases, reassured that the techniques we use in Montreal are,
at least we believe, the right ones.
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With respect to recoarctation, the patients who required
reoperation for recoarctation also required reoperation for
other reasons. There were patients, usually in the group with
hypoplastic left heart complex, who required reoperation at
the same time for recurrent residual LVOT obstruction. I
think that if we deal exclusively with an isolated recoarctation
at the distal end with a nicely enlarged aortic arch, we would
agree that the appropriate management would be balloon
dilatation.
With respect to the 5 patients subjected to enlargement of
the hypoplastic aortic arch in the absence of coarctation, this
really goes along with our overall philosophy for these
patients. I believe that if you leave tubular hypoplasia behind
in a patient with isolated coarctation after repair with a nor-
mal heart, the normal heart will overcome the anatomic after-
load and that arch will probably grow. If you have tubular
hypoplasia of the aortic arch after coarctation repair in addi-
tion to intracardiac defects, however, that relative hypoplasia
or that relative anatomic afterload will have to be faced by the
unrepaired heart. Furthermore, leaving the tubular hypoplasia
behind in a repaired heart that has to recover from the
ischemic insults may also lead to problems. We have there-
fore taken the philosophic approach that all these patients
with tubular hypoplasia with complex intracardiac malforma-
tions should undergo enlargement.
This approach was actually confirmed in 1 patient in this
series whom I classified as belonging to the single-stage
group. Actually this patient had a borderline aortic arch of 5
mm according to Roger Mee’s criteria, the weight of the baby
+ 1 mm, and I thought that this arch would be adequate. After
the switch operation and the VSD closure, approximately half
an hour after coming off cardiopulmonary bypass, the patient
had a rapid progressive deterioration to the point of near
arrest. On 2 occasions resuscitation on bypass did not prevent
the further episode. We decided to take the whole switch
down, enlarge the aortic arch, and redo the switch. After 10
hours in the operating room and close to 4 hours of cross-
clamp time, the patient came off bypass with ease and gave us
no trouble afterward. This really confirmed for me that, in
some patients without coarctation but with hypoplasia of the
aortic arch and complex intracardiac defects, this hypoplasia
has to be addressed.
With respect to the indications for the single-stage
approach, I agree with you that there will be some, in my
opinion rare, exceptions. We have learned today from other
presentations that there are ways to handle the patients with
multiple VSDs, and I think that every patient has to be treat-
ed on an individual basis. I think that some of these patients,
even if they undergo palliation, are not going to do well, so
we have taken the approach that we may as well go with a sin-
gle-stage operation. Perhaps some patients with a difficult
multiple VSD swiss-cheese septum may be excluded in our
institution as well.
With respect to the question of straddling of the tricuspid
valve, you have published techniques for dealing with that
straddling. I think that in many of those situations straddling,
unless it is the type C severe straddling, can perhaps be han-
dled at the same time.
With respect to the recoarctation rate among the patients
with hypoplastic left heart complex, it is puzzling to us on
reviewing the data that all these recoarctations happened in
the group of patients with multiple left-sided obstructions. I
cannot explain that. I can only advance a hypothesis that per-
haps in those patients the residual hypoplasia of the left ven-
tricle and the inflow and outflow tracts perhaps led to inade-
quate volume and pressure loading of the repaired aortic arch
and perhaps allowed the pulmonary homograft patch to re-
gress somewhat and not fully expand. This is something that
we obviously have to observe, with increased follow-up.
Dr Frank L. Hanley (San Francisco, Calif). Getting back
to the specifics of the arch, I think that you are stretching to
try to make a physiologic argument for the recurrent arch
obstruction in certain patients. One would think that if there
is not enough flow to stimulate arch growth, there would be
some other global manifestation of low output as well. There
is an awful lot of experience around the world with this type
of arch reconstruction with nonviable homograft material
crossing ductal tissue, and I think that one can reliably state
that no matter how well you do this operation initially there
is going to be a defined incidence of recoarctation because
you have nonviable tissue crossing ductal tissue. It is not
unreasonable to expect that recurrence in a large series of
these 2-ventricle arch repairs that would be similar to that
seen after Norwood operations, for example.
There are alternative ways to repair these arches, particu-
larly in patients with transposition and a large mismatch
between the aorta and the main pulmonary artery, in hearts
with Taussig-Bing syndrome and interrupted arches or coarc-
tations, and in cases of transposition with coarctation, where
you have a diffusely small ascending aorta from right above
the valve all the way around the arch. We have had favorable
results with transecting the aorta just above the aortic valve
and then swinging the ascending aorta transversely and con-
necting it end to end to the descending aorta, so that the
hypoplastic ascending aorta becomes a transverse aorta. After
the Lecompte maneuver, the proximal main pulmonary artery
is connected into that newly directed transverse arch without
artificial material.
Dr Tchervenkov. I agree that there are several ways to
approach this situation, and I am certainly aware of your tech-
nique for the patients with interrupted aortic arch whom you
described. What we are discussing here is our technique that
has been consistently applied through a 9-year period, without
changing every month or every year because of an unfavorable
outcome, and we are simply presenting the results of this
approach during this period. It is possible that in some situa-
tions we may evolve. For example, a way to avoid leaving the
coarctation shelf behind and the abnormal tissue is to simply
resect that area, do a partial anastomosis, and then enlarge the
undersurface with a homograft patch. 
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